Client Management | Digital KYC | Transactions | Investor App | AUM & Brokerage Reports | Lead Management | Automated Follow-Ups | MF Research | Multi-Asset Tracking
Login
Get Started
Home Mf Research Iti Pharma And Healthcare Fund Regular Plan Growth
ITI MUTUAL FUND

Mutual Fund Research

ITI Pharma And Healthcare Fund - Regular Plan - Growth

ITI MUTUAL FUND Equity Equity Sectoral Thematic

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-27 ₹1,000.00 ₹1,032.87 +3.29%
Two Week 2026-10-19 ₹1,000.00 ₹1,054.52 +5.45%
One Month 2026-10-05 ₹1,000.00 ₹1,018.64 +1.86%
Three Months 2026-08-05 ₹3,000.00 ₹2,989.45 -0.35%
Six Months 2026-05-07 ₹6,000.00 ₹6,146.96 +2.45%
One Year 2025-11-03 ₹12,000.00 ₹13,049.62 +8.75%
Three Year 2023-11-06 ₹36,000.00 ₹41,959.05 +16.55%
Since Inception 2021-11-08 ₹61,000.00 ₹87,735.06 +43.83%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 74.79%
Healthcare Services 20.90%
Healthcare Equipment & Supplies 1.48%
Consumer Durables 1.22%
Chemicals & Petrochemicals 0.92%
Other 0.69%

Top Holdings

Company-wise portfolio exposure

Sun Pharmaceutical Industries Limited 11.96%
Divi's Laboratories Limited 9.51%
Apollo Hospitals Enterprise Limited 5.45%
Dr. Reddy's Laboratories Limited 4.78%
Torrent Pharmaceuticals Limited 4.78%
Max Healthcare Institute Limited 4.49%
Cipla Limited 4.19%
Laurus Labs Limited 4.02%
Aurobindo Pharma Limited 4.01%
Mankind Pharma Limited 3.78%
Cohance Lifesciences Limited 3.14%
Alkem Laboratories Limited 3.09%
Neuland Laboratories Limited 3.07%
Global Health Limited 2.85%
Fortis Healthcare Limited 2.77%
Abbott India Limited 2.14%
Lupin Limited 2.04%
IPCA Laboratories Limited 1.94%
Sai Life Sciences Limited 1.87%
Shilpa Medicare Limited 1.61%
Aster DM Quality Care Limited 1.59%
Poly Medicure Limited 1.48%
Healthcare Global Enterprises Limited 1.47%
Piramal Pharma Limited 1.27%
Anthem Biosciences Limited 1.25%
Shaily Engineering Plastics Limited 1.22%
Glenmark Pharmaceuticals Limited 1.13%
Gland Pharma Limited 1.03%
Supriya Lifescience Limited 1.00%
Rainbow Childrens Medicare Limited 1.00%
GlaxoSmithKline Pharmaceuticals Limited 0.96%
Linde India Limited 0.92%
Biocon Limited 0.81%
Zydus Lifesciences Limited 0.73%
Metropolis Healthcare Limited 0.71%
Caplin Point Laboratories Limited 0.68%
Syngene International Limited 0.57%
Net Receivables / (Payables) 0.69%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
16.74%
Return volatility
β
Beta
0.95
Benchmark sensitivity
S
Sharpe Ratio
0.7
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Peer Comparison

Compare similar mutual funds by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
Nippon India Taiwan Equity Fund - Regular Plan - Growth 72.09% 52.20% 24.94%
HDFC Pharma And Healthcare Fund - Regular Plan - Growth 22.96% 28.71% 27.73%
Kotak Healthcare Fund - Regular Plan - Growth 21.39% 0.00% 18.89%
ICICI Prudential US Bluechip Equity Fund - Regular Plan - Growth 20.17% 18.45% 15.90%
Nippon India - Japan Equity Fund - Regular Plan - Growth 20.05% 20.38% 8.48%
SBI Automotive Opportunities Fund - Regular Plan - Growth 18.05% 0.00% 10.40%
Whiteoak Capital - Pharma And Healthcare Fund - Regular Plan - Growth 17.93% 0.00% 19.92%
Franklin Asian Equity Fund - Regular Plan - Growth 17.86% 20.14% 7.88%
Bajaj Finserv Healthcare Fund - Regular Plan - Growth 17.69% 0.00% 8.16%
Mirae Asset Healthcare Fund - Regular Plan - Growth 17.66% 21.74% 19.93%

Returns are historical and do not guarantee future performance.

View All Equity Sectoral Thematic Funds

Fund Family

Compare schemes from ITI MUTUAL FUND by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
ITI Small Cap Fund - Regular Plan - Growth 10.69% 19.63% 18.98%
ITI Pharma And Healthcare Fund - Regular Plan - Growth 8.38% 17.74% 12.09%
ITI Flexi Cap Fund - Regular Plan - Growth 6.50% 16.26% 19.44%
ITI Liquid Fund - Regular Plan - Growth 5.97% 6.48% 5.24%
ITI Multi Cap Fund - Regular Plan - Growth 5.78% 14.17% 13.18%
ITI Arbitrage Fund - Regular Plan - Growth 5.70% 6.48% 4.77%
ITI Ultra Short Term Fund - Regular Plan - Growth 5.51% 6.15% 5.31%
ITI Overnight Fund - Regular Plan - Growth 4.91% 5.68% 4.83%
ITI Banking And PSU Fund - Regular Plan - Growth 3.59% 6.21% 5.44%
ITI Dynamic Term Fund - Regular Plan - Growth 0.42% 4.60% 4.49%

Returns are historical and do not guarantee future performance.

View All ITI MUTUAL FUND Funds

Scheme Objective

The investment mandate and purpose of this scheme

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
2.62%
Expense Ratio (Direct)
0.92%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
Nifty Healthcare TRI

Exit Load

Charges that may apply when you redeem units

If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50% Exit Load after completion of 3 months - NIL
Top AMC/Fund Houses
360 ONE Mutual Fund AMC logo
360 ONE Mutual Fund
AUM
₹13,053 Cr
Age
15+ Years
Aditya Birla Sun Life Mutual Fund AMC logo
Aditya Birla Sun Life Mutual Fund
AUM
₹4.36 Lakh Cr
Age
31+ Years
Helios Mutual Fund AMC logo
Helios Mutual Fund
AUM
₹9,401 Cr
Age
1–2 Years
Bandhan Mutual Fund AMC logo
Bandhan Mutual Fund
AUM
₹1.78+ Lakh Cr
Age
4 Years
view all

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?